This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Hologic Inc (HOLX): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Hologic (
HOLX) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.6%. By the end of trading, Hologic fell $1.14 (-5.2%) to $20.54 on heavy volume. Throughout the day, 10,226,256 shares of Hologic exchanged hands as compared to its average daily volume of 3,278,700 shares. The stock ranged in price between $20.33-$21.80 after having opened the day at $21.77 as compared to the previous trading day's close of $21.67. Other companies within the Health Care sector that declined today were:
Neurocrine Biosciences (
NBIX), down 29.7%,
Chemocentryx (
CCXI), down 24.3%,
IMRIS (
IMRS), down 9.3% and
SunLink Health Systems (
SSY), down 8.7%.

Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. Hologic has a market cap of $5.8 billion and is part of the health services industry. Shares are up 6.9% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates
Hologic as a
buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.